+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

In Vitro Lung Models Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, End User, and Geography

  • PDF Icon

    Report

  • 231 Pages
  • June 2025
  • Region: Global
  • The Insight Partners
  • ID: 6103009
The In Vitro lung models market size is projected to reach US$ 1.53 billion by 2031 from US$ 446.35 million in 2024. The market is estimated to register a CAGR of 19.4% during 2025-2031. Major factors driving the market growth include a surging prevalence of respiratory diseases and the rising adoption of in vitro models as an alternative to animal testing. Further, Applications of 3D cultures and AI in oncology is likely to boost the market during the forecast period. However, lack of skilled professionals are among the market deterrents.

According to a report published by the Global Initiative on Chronic Obstructive Lung Disease, ~65 million people suffer from obstructive pulmonary disease (COPD), and nearly 3 million people die from the disease each year, making it the fourth leading cause of mortality worldwide. According to the 2023 American Lung Association data, ~34 million Americans were affected by chronic lung diseases such as asthma and COPD. In 2022, ~11.7 million adults, or 4.6% of the population in the US, were diagnosed with COPD. As per an article published in the European Respiratory Journal in 2020, 36.58 million Europeans were reported to have COPD, which is projected to reach 49.45 million by 2050, representing a 35.2% relative increase.

With the growing prevalence of smoking in developing countries and the aging population in high-income countries, the COPD prevalence is projected to rise over the next forty years. As per the World Health Organization (WHO) estimates, COPD will become one of the leading causes of death worldwide by 2030, and it is estimated that by 2060, there will be more than 5.4 million deaths yearly due to COPD and related conditions.

Therefore, respiratory diseases is spurring the demand for advanced research models to understand disease mechanisms and develop effective treatments.

In vitro lung models, such as precision-cut lung slices (PCLS), allow the study of airway constriction and inflammation, facilitating the evaluation of novel therapeutic targets for asthma and other respiratory conditions. Lung-on-a-chip devices have been developed to replicate the physiological conditions of the human lung. The University of Michigan's "lung-on-a-chip" device uses human lung-tissue cells cultured on a plastic chip with microscopic channels to simulate the conditions inside the lungs, providing new insights into diseases. Thus, the increasing demand for effective treatments and research models fuels the growth of the in vitro lung model market.

Moreover, two-dimensional (2D) cell cultures, or monolayers, are widely used in cellular biology to study diseases and for drug screening due to their cost-effectiveness, high throughput, easy replication, and results interpretation. However, they fall short in replicating the complex network of dynamic interactions present in the three-dimensional tumor microenvironment (TME) of living patient tumors. This aspect limits their ability to model cancer behavior and drug responses, as well as to isolate and maintain cancer cell lines from patient biopsies in 2D cultures. Traditional 2D cell cultures, while foundational, fall short in replicating the intricate TME and cellular interactions that characterize lung cancers in vivo.

As cancer research advances, an increasing number of animals are being utilized in the creation of animal models. These animals include mice, rats, and other similar species. However, animal models exhibit low success rates in translating preclinical findings into effective clinical treatments; this has raised concerns about their reliability as predictors of human responses. To address these limitations, research is shifting toward more physiologically relevant human in vitro models (3D cell culture models) - such as spheroids, organoids, tumoroids, and microfluidic systems - that better mimic the TME, gene expression, and drug responses observed clinically.

These models are critical for validating drug efficacy and improving preclinical testing, especially in lung cancer research. Integrating 3D models in drug screening is essential to validate findings from 2D cultures and assess the effects of anticancer drugs. Such approaches have proven to be fruitful for cancer drug screening and are emerging as a pivotal tool in shaping the future of lung cancer research and therapeutic development. The use of 3D cell culture models in lung cancer pharmacology research represents a paradigm shift in the approach toward understanding and treating lung diseases.

The comparative company analysis evaluates and categorizes the in vitro lung models market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape.

The report profoundly explores the recent significant developments and innovations by the leading vendors in the global in vitro lung models market. The key market players are MatTek Corp, Lonza Group AG, Emulate, Inc, CN Bio Innovations Ltd, PromoCell GmbH, Charles River Laboratories International Inc, MIMETAS BV, InSphero AG, Organovo Holdings Inc, Draper, Inc, Epithelix, AlveoliX AG, and American Type Culture Collection (ATCC).

Based on type, the market is divided into 3D Models and 2D Models. The 3D Models segment held the largest In Vitro Lung Model Market share in 2024, and it is expected to register the highest CAGR during 2024-2031.

3D lung models replicate the complex architecture and cellular interactions of human lung tissue accurately. The enhanced physiological relevance makes them invaluable for drug discovery, toxicity testing, and disease modeling. The primary types of 3D lung models include spheroids, organoids, and precision-cut lung slices (PCLS). In 3D models, cells are cultured within a three-dimensional structure, offering advantages over traditional 2D models. These models closely replicate the architecture and microenvironment of the lung, enabling accurate simulation of physiological conditions. As a result, drug and therapeutic studies using 3D models tend to yield more accurate and reliable results than those derived from 2D models or animal models.

By application, In Vitro Lung Model market is segmented into drug discovery and toxicology studies, physiological research, regenerative medicine, and others. The drug discovery and toxicology studies segment held the largest share of the in vitro lung model market in 2024.

Per end user, In Vitro Lung Model market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and others. The pharmaceutical and biotechnology companies segment held the largest share of the In Vitro lung model market in 2024.

Various organic and inorganic strategies are adopted by companies operating in the in vitro lung models market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few of the significant developments by key players in the in vitro lung models market are listed below.

In September 2024, MatTek Life Sciences, a biotech company specializing in the development of in vitro human tissues, announced the licensing of its organotypic human tissues to CellEx, a life science laboratory based in China. This strategic collaboration marks a milestone in the advancement and utilization of human tissues for research, pharmaceutical development, and safety assessment applications.

In June 2023, Emulate, Inc., a provider of next-generation in vitro models, announced the launch of the Emulate Chip-A1 Accessible Chip through an early access program. This new Organ-Chip design expands on the original Chip-S1 - which models tissue-vascular interfaces with relevant biomechanical forces such as stretch and flow - by allowing users to create thicker tissues within the epithelial culture chamber and apply additional drug treatment options, including topical or aerosolized applications.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the in vitro lung models market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global invitro lung models market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents

1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Analyst Market Outlook
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
3.3 Assumptions and Limitations
4. In-Vitro Lung Model Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Regulatory Scenario
5. In-Vitro Lung Model Market - Key Market Dynamics
5.1 In-Vitro Lung Model Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Surging Prevalence of Respiratory Diseases
5.2.2 Rising Adoption of In Vitro Models as an Alternative to Animal Testing
5.3 Market Restraints
5.3.1 Lack of Skilled Professionals
5.4 Market Opportunities
5.4.1 Surging Funding and Investments for In Vitro Models
5.5 Future Trends
5.5.1 Application of 3D Cultures and AI in Oncology
5.6 Impact of Drivers and Restraints:
6. In-Vitro Lung Model Market - Global Market Analysis
6.1 In-Vitro Lung Model Market Revenue (US$ Million), 2021-2031
6.2 In-Vitro Lung Model Market Forecast Analysis
7. In-Vitro Lung Model Market Analysis - by Type
7.1 3D Model
7.1.1 Overview
7.1.2 3D Model: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
7.2 2D Model
7.2.1 Overview
7.2.2 2D Model: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
8. In-Vitro Lung Model Market Analysis - by Application
8.1 Drug Discovery and Toxicology Studies
8.1.1 Overview
8.1.2 Drug Discovery and Toxicology Studies: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Physiological Research
8.2.1 Overview
8.2.2 Physiological Research: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Regenerative Medicine
8.3.1 Overview
8.3.2 Regenerative Medicine: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
9. In-Vitro Lung Model Market Analysis - by End User
9.1 Pharmaceutical and Biotechnology Companies
9.1.1 Overview
9.1.2 Pharmaceutical and Biotechnology Companies: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Academic and Research Institutes
9.2.1 Overview
9.2.2 Academic and Research Institutes: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
10. In-Vitro Lung Model Market - Geographical Analysis
10.1 Overview
10.2 North America
10.2.1 North America In-Vitro Lung Model Market Overview
10.2.2 North America: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
10.2.3 North America: In-Vitro Lung Model Market Breakdown, by Type
10.2.3.1 North America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Type
10.2.4 North America: In-Vitro Lung Model Market Breakdown, by Application
10.2.4.1 North America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Application
10.2.5 North America: In-Vitro Lung Model Market Breakdown, by End User
10.2.5.1 North America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by End User
10.2.6 North America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
10.2.6.1 North America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
10.2.6.2 United States: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.2.6.2.1 United States: In-Vitro Lung Model Market Breakdown, by Type
10.2.6.2.2 United States: In-Vitro Lung Model Market Breakdown, by Application
10.2.6.2.3 United States: In-Vitro Lung Model Market Breakdown, by End User
10.2.6.3 Canada: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.2.6.3.1 Canada: In-Vitro Lung Model Market Breakdown, by Type
10.2.6.3.2 Canada: In-Vitro Lung Model Market Breakdown, by Application
10.2.6.4 Mexico: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.2.6.4.1 Mexico: In-Vitro Lung Model Market Breakdown, by Type
10.2.6.4.2 Mexico: In-Vitro Lung Model Market Breakdown, by Application
10.2.6.4.3 Mexico: In-Vitro Lung Model Market Breakdown, by End User
10.3 Europe
10.3.1 Europe In-Vitro Lung Model Market Overview
10.3.2 Europe: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
10.3.3 Europe: In-Vitro Lung Model Market Breakdown, by Type
10.3.3.1 Europe: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Type
10.3.4 Europe: In-Vitro Lung Model Market Breakdown, by Application
10.3.4.1 Europe: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Application
10.3.5 Europe: In-Vitro Lung Model Market Breakdown, by End User
10.3.5.1 Europe: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by End User
10.3.6 Europe: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
10.3.6.1 Europe: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
10.3.6.2 Germany: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.3.6.2.1 Germany: In-Vitro Lung Model Market Breakdown, by Type
10.3.6.2.2 Germany: In-Vitro Lung Model Market Breakdown, by Application
10.3.6.2.3 Germany: In-Vitro Lung Model Market Breakdown, by End User
10.3.6.3 France: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.3.6.3.1 France: In-Vitro Lung Model Market Breakdown, by Type
10.3.6.3.2 France: In-Vitro Lung Model Market Breakdown, by Application
10.3.6.3.3 France: In-Vitro Lung Model Market Breakdown, by End User
10.3.6.4 United Kingdom: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.3.6.4.1 United Kingdom: In-Vitro Lung Model Market Breakdown, by Type
10.3.6.4.2 United Kingdom: In-Vitro Lung Model Market Breakdown, by Application
10.3.6.4.3 United Kingdom: In-Vitro Lung Model Market Breakdown, by End User
10.3.6.5 Italy: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.3.6.5.1 Italy: In-Vitro Lung Model Market Breakdown, by Type
10.3.6.5.2 Italy: In-Vitro Lung Model Market Breakdown, by Application
10.3.6.5.3 Italy: In-Vitro Lung Model Market Breakdown, by End User
10.3.6.6 Spain: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.3.6.6.1 Spain: In-Vitro Lung Model Market Breakdown, by Type
10.3.6.6.2 Spain: In-Vitro Lung Model Market Breakdown, by Application
10.3.6.6.3 Spain: In-Vitro Lung Model Market Breakdown, by End User
10.3.6.7 Rest of Europe: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.3.6.7.1 Rest of Europe: In-Vitro Lung Model Market Breakdown, by Type
10.3.6.7.2 Rest of Europe: In-Vitro Lung Model Market Breakdown, by Application
10.3.6.7.3 Rest of Europe: In-Vitro Lung Model Market Breakdown, by End User
10.4 Asia Pacific
10.4.1 Asia Pacific In-Vitro Lung Model Market Overview
10.4.2 Asia Pacific: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
10.4.3 Asia Pacific: In-Vitro Lung Model Market Breakdown, by Type
10.4.3.1 Asia Pacific: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Type
10.4.4 Asia Pacific: In-Vitro Lung Model Market Breakdown, by Application
10.4.4.1 Asia Pacific: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Application
10.4.4.2 Asia Pacific: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by End User
10.4.5 Asia Pacific: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
10.4.5.1 Asia Pacific: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
10.4.5.2 China: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.4.5.2.1 China: In-Vitro Lung Model Market Breakdown, by Type
10.4.5.2.2 China: In-Vitro Lung Model Market Breakdown, by Application
10.4.5.2.3 China: In-Vitro Lung Model Market Breakdown, by End User
10.4.5.3 Japan: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.4.5.3.1 Japan: In-Vitro Lung Model Market Breakdown, by Type
10.4.5.3.2 Japan: In-Vitro Lung Model Market Breakdown, by Application
10.4.5.3.3 Japan: In-Vitro Lung Model Market Breakdown, by End User
10.4.5.4 India: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.4.5.4.1 India: In-Vitro Lung Model Market Breakdown, by Type
10.4.5.4.2 India: In-Vitro Lung Model Market Breakdown, by Application
10.4.5.4.3 India: In-Vitro Lung Model Market Breakdown, by End User
10.4.5.5 South Korea: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.4.5.5.1 South Korea: In-Vitro Lung Model Market Breakdown, by Type
10.4.5.5.2 South Korea: In-Vitro Lung Model Market Breakdown, by Application
10.4.5.5.3 South Korea: In-Vitro Lung Model Market Breakdown, by End User
10.4.5.6 Australia: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.4.5.6.1 Australia: In-Vitro Lung Model Market Breakdown, by Type
10.4.5.6.2 Australia: In-Vitro Lung Model Market Breakdown, by Application
10.4.5.6.3 Australia: In-Vitro Lung Model Market Breakdown, by End User
10.4.5.7 Rest of APAC: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.4.5.7.1 Rest of APAC: In-Vitro Lung Model Market Breakdown, by Type
10.4.5.7.2 Rest of APAC: In-Vitro Lung Model Market Breakdown, by Application
10.4.5.7.3 Rest of APAC: In-Vitro Lung Model Market Breakdown, by End User
10.5 Middle East and Africa
10.5.1 Middle East and Africa In-Vitro Lung Model Market Overview
10.5.2 Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
10.5.3 Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Type
10.5.3.1 Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Type
10.5.4 Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Application
10.5.4.1 Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Application
10.5.5 Middle East and Africa: In-Vitro Lung Model Market Breakdown, by End User
10.5.5.1 Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by End User
10.5.6 Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
10.5.6.1 Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
10.5.6.2 Saudi Arabia: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.5.6.2.1 Saudi Arabia: In-Vitro Lung Model Market Breakdown, by Type
10.5.6.2.2 Saudi Arabia: In-Vitro Lung Model Market Breakdown, by Application
10.5.6.2.3 Saudi Arabia: In-Vitro Lung Model Market Breakdown, by End User
10.5.6.3 South Africa: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.5.6.3.1 South Africa: In-Vitro Lung Model Market Breakdown, by Type
10.5.6.3.2 South Africa: In-Vitro Lung Model Market Breakdown, by Application
10.5.6.3.3 South Africa: In-Vitro Lung Model Market Breakdown, by End User
10.5.6.4 United Arab Emirates: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.5.6.4.1 United Arab Emirates: In-Vitro Lung Model Market Breakdown, by Type
10.5.6.4.2 United Arab Emirates: In-Vitro Lung Model Market Breakdown, by Application
10.5.6.4.3 United Arab Emirates: In-Vitro Lung Model Market Breakdown, by End User
10.5.6.5 Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.5.6.5.1 Rest of Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Type
10.5.6.5.2 Rest of Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Application
10.5.6.5.3 Rest of Middle East and Africa: In-Vitro Lung Model Market Breakdown, by End User
10.6 South and Central America
10.6.1 South and Central America In-Vitro Lung Model Market Overview
10.6.2 South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
10.6.3 South and Central America: In-Vitro Lung Model Market Breakdown, by Type
10.6.3.1 South and Central America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Type
10.6.4 South and Central America: In-Vitro Lung Model Market Breakdown, by Application
10.6.4.1 South and Central America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Application
10.6.5 South and Central America: In-Vitro Lung Model Market Breakdown, by End User
10.6.5.1 South and Central America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by End User
10.6.6 South and Central America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
10.6.6.1 South and Central America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
10.6.6.2 Brazil: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.6.6.2.1 Brazil: In-Vitro Lung Model Market Breakdown, by Type
10.6.6.2.2 Brazil: In-Vitro Lung Model Market Breakdown, by Application
10.6.6.2.3 Brazil: In-Vitro Lung Model Market Breakdown, by End User
10.6.6.3 Argentina: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.6.6.3.1 Argentina: In-Vitro Lung Model Market Breakdown, by Type
10.6.6.3.2 Argentina: In-Vitro Lung Model Market Breakdown, by Application
10.6.6.3.3 Argentina: In-Vitro Lung Model Market Breakdown, by End User
10.6.6.4 Rest of South and Central America: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.6.6.4.1 Rest of South and Central America: In-Vitro Lung Model Market Breakdown, by Type
10.6.6.4.2 Rest of South and Central America: In-Vitro Lung Model Market Breakdown, by Application
10.6.6.4.3 Rest of South and Central America: In-Vitro Lung Model Market Breakdown, by End User
11. Industry Landscape
11.1 Overview
11.2 New Product Development
11.3 Merger and Acquisition
11.4 Partnerships and Collaborations
11.5 Other Business Strategies
12. Competitive Landscape
12.1 Global Company Market Share Analysis, 2024
13. Company Profiles
13.1 MatTek Corp
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Lonza Group AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Emulate, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 CN Bio Innovations Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Merck KGaA
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 PromoCell GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.7 Charles River Laboratories International Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 MIMETAS BV
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 InSphero AG
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Organovo Holdings Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Draper, Inc.
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 TissUse GmbH
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.13 Epithelix
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Financial Overview
13.13.4 SWOT Analysis
13.13.5 Key Developments
13.14 AlveoliX AG
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 American Type Culture Collection (ATCC)
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms
List of Tables
Table 1. In-Vitro Lung Model Market Segmentation
Table 2. In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million)
Table 3. In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million)
Table 4. In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 5. In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 6. In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 7. In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 8. In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 9. In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 10. North America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 11. North America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 12. North America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 13. North America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 14. North America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 15. North America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 16. North America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Country
Table 17. North America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
Table 18. United States: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 19. United States: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 20. United States: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 21. United States: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 22. United States: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 23. United States: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 24. Canada: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 25. Canada: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 26. Canada: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 27. Canada: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 28. Mexico: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 29. Mexico: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 30. Mexico: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 31. Mexico: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 32. Mexico: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 33. Mexico: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 34. Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 35. Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 36. Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 37. Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 38. Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 39. Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 40. Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Country
Table 41. Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
Table 42. Germany: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 43. Germany: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 44. Germany: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 45. Germany: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 46. Germany: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 47. Germany: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 48. France: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 49. France: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 50. France: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 51. France: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 52. France: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 53. France: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 54. United Kingdom: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 55. United Kingdom: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 56. United Kingdom: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 57. United Kingdom: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 58. United Kingdom: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 59. United Kingdom: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 60. Italy: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 61. Italy: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 62. Italy: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 63. Italy: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 64. Italy: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 65. Italy: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 66. Spain: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 67. Spain: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 68. Spain: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 69. Spain: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 70. Spain: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 71. Spain: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 72. Rest of Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 73. Rest of Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 74. Rest of Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 75. Rest of Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 76. Rest of Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 77. Rest of Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 78. Asia Pacific: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 79. Asia Pacific: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 80. Asia Pacific: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 81. Asia Pacific: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 82. Asia Pacific: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 83. Asia Pacific: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 84. Asia Pacific: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Country
Table 85. Asia Pacific: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
Table 86. China: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 87. China: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 88. China: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 89. China: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 90. China: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 91. China: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 92. Japan: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 93. Japan: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 94. Japan: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 95. Japan: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 96. Japan: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 97. Japan: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 98. India: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 99. India: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 100. India: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 101. India: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 102. India: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 103. India: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 104. South Korea: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 105. South Korea: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 106. South Korea: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 107. South Korea: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 108. South Korea: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 109. South Korea: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 110. Australia: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 111. Australia: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 112. Australia: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 113. Australia: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 114. Australia: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 115. Australia: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 116. Rest of APAC: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 117. Rest of APAC: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 118. Rest of APAC: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 119. Rest of APAC: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 120. Rest of APAC: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 121. Rest of APAC: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 122. Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 123. Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 124. Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 125. Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 126. Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 127. Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 128. Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Country
Table 129. Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
Table 130. Saudi Arabia: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 131. Saudi Arabia: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 132. Saudi Arabia: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 133. Saudi Arabia: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 134. Saudi Arabia: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 135. Saudi Arabia: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 136. South Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 137. South Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 138. South Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 139. South Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 140. South Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 141. South Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 142. United Arab Emirates: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 143. United Arab Emirates: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 144. United Arab Emirates: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 145. United Arab Emirates: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 146. United Arab Emirates: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 147. United Arab Emirates: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 148. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 149. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 150. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 151. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 152. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 153. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 154. South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 155. South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 156. South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 157. South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 158. South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 159. South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 160. South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Country
Table 161. South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
Table 162. Brazil: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 163. Brazil: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 164. Brazil: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 165. Brazil: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 166. Brazil: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 167. Brazil: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 168. Argentina: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 169. Argentina: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 170. Argentina: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 171. Argentina: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 172. Argentina: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 173. Argentina: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 174. Rest of South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
Table 175. Rest of South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
Table 176. Rest of South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
Table 177. Rest of South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
Table 178. Rest of South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
Table 179. Rest of South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
Table 180. Glossary of Terms, In-Vitro Lung Model Market
List of Figures
Figure 1. In-Vitro Lung Model Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. In-Vitro Lung Model Market Revenue (US$ Million), 2021-2031
Figure 5. In-Vitro Lung Model Market Share (%) - by Type (2024 and 2031)
Figure 6. 3D Model: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. 2D Model: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. In-Vitro Lung Model Market Share (%) - by Application (2024 and 2031)
Figure 9. Drug Discovery and Toxicology Studies: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Physiological Research: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Regenerative Medicine: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Others: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. In-Vitro Lung Model Market Share (%) - by End User (2024 and 2031)
Figure 14. Pharmaceutical and Biotechnology Companies: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Academic and Research Institutes: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Others: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. In-Vitro Lung Model Market Breakdown by Region, 2024 and 2031 (%)
Figure 18. North America: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
Figure 19. North America: In-Vitro Lung Model Market Breakdown, by Type (2024 and 2031)
Figure 20. North America: In-Vitro Lung Model Market Breakdown, by Application (2024 and 2031)
Figure 21. North America: In-Vitro Lung Model Market Breakdown, by End User (2024 and 2031)
Figure 22. North America: In-Vitro Lung Model Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 23. United States: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 24. Canada: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 25. Mexico: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 26. Europe: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
Figure 27. Europe: In-Vitro Lung Model Market Breakdown, by Type (2024 and 2031)
Figure 28. Europe: In-Vitro Lung Model Market Breakdown, by Application (2024 and 2031)
Figure 29. Europe: In-Vitro Lung Model Market Breakdown, by End User (2024 and 2031)
Figure 30. Europe: In-Vitro Lung Model Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 31. Germany: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 32. France: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 33. United Kingdom: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 34. Italy: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 35. Spain: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 36. Rest of Europe: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 37. Asia Pacific: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
Figure 38. Asia Pacific: In-Vitro Lung Model Market Breakdown, by Type (2024 and 2031)
Figure 39. Asia Pacific: In-Vitro Lung Model Market Breakdown, by Application (2024 and 2031)
Figure 40. Asia Pacific: In-Vitro Lung Model Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 41. China: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 42. Japan: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 43. India: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 44. South Korea: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 45. Australia: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 46. Rest of APAC: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 47. Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
Figure 48. Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Type (2024 and 2031)
Figure 49. Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Application (2024 and 2031)
Figure 50. Middle East and Africa: In-Vitro Lung Model Market Breakdown, by End User (2024 and 2031)
Figure 51. Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 52. Saudi Arabia: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 53. South Africa: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 54. United Arab Emirates: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 55. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 56. South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
Figure 57. South and Central America: In-Vitro Lung Model Market Breakdown, by Type (2024 and 2031)
Figure 58. South and Central America: In-Vitro Lung Model Market Breakdown, by Application (2024 and 2031)
Figure 59. South and Central America: In-Vitro Lung Model Market Breakdown, by End User (2024 and 2031)
Figure 60. South and Central America: In-Vitro Lung Model Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 61. Brazil: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 62. Argentina: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 63. Rest of South and Central America: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 64. Global Company Market Share Analysis, 2024

Companies Mentioned

Some of the leading companies in the In Vitro Lung Models Market include:
  • MatTek Corp
  • Lonza Group AG
  • Emulate, Inc
  • CN Bio Innovations Ltd
  • PromoCell GmbH
  • Charles River Laboratories International Inc
  • MIMETAS BV
  • InSphero AG
  • Organovo Holdings Inc
  • Draper, Inc
  • Epithelix, AlveoliX AG
  • American Type Culture Collection (ATCC)

Table Information